Enanta Pharmaceuticals
ENTA
#8714
Rank
A$0.34 B
Marketcap
A$11.97
Share price
-3.04%
Change (1 day)
-35.93%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -A$74.12 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are A$65.25 Million. In 2025 the company made an earning of -A$95.98 Million, an increase over its 2024 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$74.12 Million-22.78%
2025 -A$95.98 Million-34.07%
2024 -A$0.15 Billion-23.87%
2023 -A$0.2 Billion4.39%
2022 -A$0.19 Billion-4.4%
2021 -A$0.2 Billion91.12%
2020 -A$0.11 Billion-407.13%
2019 A$32.64 M-78.63%
2018 A$0.15 B117.97%
2017 A$70.08 M-574.65%
2016 -A$14.77 Million-110.83%
2015 A$0.13 B-4.5%
2014 A$0.14 B-638.53%
2013 -A$26.52 Million-137.98%
2012 A$69.81 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.09 B-37,381.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.97 B-25,277.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$19.22 B-25,618.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.84 B-9,183.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.08 B-13,488.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.00 B-22,666.96%๐Ÿ‡บ๐Ÿ‡ธ USA